Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy
- PMID: 29763342
- DOI: 10.1200/JCO.2018.78.8240
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy
Comment in
-
Reply to M.S. Copur et al.J Clin Oncol. 2018 Jul 1;36(19):2007. doi: 10.1200/JCO.2018.78.9834. Epub 2018 May 15. J Clin Oncol. 2018. PMID: 29763341 No abstract available.
Comment on
-
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update.J Clin Oncol. 2018 Mar 20;36(9):911-919. doi: 10.1200/JCO.2017.76.7293. Epub 2018 Feb 5. J Clin Oncol. 2018. PMID: 29401004
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
